Functional Analysis of Tumor Driver Genes Based on Gene Knockout Cell Lines and Applications in Disease Models

Why Cancer Research Needs Gene Knockout Cell Lines

The development and progression of tumors often involve abnormal activation or inactivation of multiple driver genes. Although traditional overexpression models can mimic gene function gain, they are difficult to directly reflect the consequences of gene loss. Gene knockout cell lines, by targeted deletion of the gene of interest, enable researchers to observe the growth characteristics, cell cycle changes, and responses to therapeutic drugs of tumor cells after loss of that gene, thereby inferring the essential role of the gene in tumor maintenance. This is especially valuable in functional redundancy studies, where combinatorial models with simultaneous knockout of two or more genes help dissect key nodes in signaling pathways.

Key Considerations for Construction and Functional Validation

When constructing tumor gene knockout cell lines, it is necessary to consider the background expression level and copy number variation of the target gene in tumor cells. For common tumor cell lines such as Hela, A549, and MCF-7, publicly available genomic data can serve as references. When selecting sgRNAs, priority should be given to targeting early exons to ensure complete disruption of functional domains. Because tumor cells often exhibit genomic instability, attention must be paid to the possibility that off-target effects may introduce false-positive phenotypes. It is recommended to use at least two independent sgRNAs to construct clones separately and verify phenotype consistency. In the functional validation stage, multidimensional assessment is required, including cell proliferation, colony formation, apoptosis, migration, and invasion, combined with real-time cell analysis systems (such as xCELLigence) or flow cytometry to obtain quantitative data.

Multidimensional Methods for Phenotypic Analysis

After knockout of tumor driver genes, phenotypic analysis should cover multiple biological processes. Proliferation assays can use CCK-8 or EdU incorporation; apoptosis can be assessed by Annexin V/PI staining and Caspase-3 activation; migration and invasion are commonly evaluated using Transwell chambers or scratch assays. For genes involved in metabolic reprogramming, glucose uptake and lactate production can be further measured. In addition, xenografting knockout cell lines into immunodeficient mice can evaluate changes in in vivo tumorigenicity—an important complement for validating tumor driver function.

Applications in Drug Sensitivity and Drug Resistance Mechanism Research

Gene knockout cell lines can help identify drug targets in precision oncology. For example, for a given targeted drug, constructing a cell line with knockout of the drug target gene and observing whether it acquires resistance can conversely confirm the importance of that target for drug response. At the same time, by constructing knockout lines of known drug resistance-related genes, it is possible to assess whether their loss reverses or enhances the resistance phenotype. Such models provide cell-level experimental evidence for combination therapy strategies and also provide a reliable target validation platform for screening novel antitumor compounds.